‘Tis the season: with just about two weeks to go until the winners of the 2013 Nobel prizes are announced, speculation about who will win and who will get snubbed is once again brewing. Thomson Reuters — the firm that maintains the Journal Citation Index — released its predictions today based on, of course, citations.
Anyone who takes issue with the disproportionate attention paid to Nobel prizes or citation counts might want to look away now.
Among the noteworthy names on Thomson Reuters’ list are François Englert and Peter Higgs for their prediction of the Brout–Englert–Higgs particle in physics. In medicine, the list is topped by Adrian Bird, Howard Cedar and Aharon Razin for their discoveries in DNA methylation and gene expression. Chemists on the list include M. G. Finn, Valery Fokin and Barry Sharpless for the development of modular click chemistry.
Thomson Reuters’ full list below names multiple teams tipped each for prize. Since this forecast first began in 2002, 27 of those researchers have eventually gone on to win a Nobel.
If this all seems worthy of some (fake) money, the Nobel Exchange run by the science magazine Nautilus is open for speculation.
For contributions to DNA nanotechnology: Paul Alivisatos, Chad Mirkin and Nadrian Seeman
For the invention of the Ames test of mutagenicity: Bruce Ames
For the development of modular click chemistry: M. G. Finn, Valery Fokin and Barry Sharpless
For their prediction of the Brout–Englert–Higgs boson: François Englert and Peter Higgs
For his discovery of iron-based superconductors: Hideo Hosono
For their discoveries of extrasolar planets: Geoffrey Marcy, Michel Mayor and Didier Queloz
Physiology or medicine:
For their fundamental discoveries concerning DNA methylation: Adrian Bird, Howard Cedar and Aharon Razin
For elucidating the mechanisms and physiological function of autophagy: Daniel Klionsky, Noboru Mizushima and Yoshinori Ohsumi
For his pioneering research identifying the HER-2/neu oncogene, leading to more effective cancer therapy: Dennis Slamon